Personalized Medicine and Management of Gynecologic Cancer

Dear Colleagues,

Personalized medicine is an innovative approach to treating patients based on their genetic, molecular, and clinical profiles. This strategy will help optimize diagnosis, treatment, and prevention of gynecologic cancer by tailoring therapies to individual tumor characteristics, with the goal of improving treatment outcomes whilst minimizing side effects.

Advances in genomic research and molecular profiling have transformed cancer treatment over the past two decades, which have given impetus to the maturity of personalized medicine in the gynecologic oncology field.

The aim and scope of this special series will be to draw the reader’s attention to the latest updates and key strategies for personalized medicine in the context of gynecologic oncology.

Many cutting-edge studies and research are focused on screening for hereditary cancer syndromes, genomic profiling, and utilizing specialized drug therapies using hormonal therapy, PARP inhibitors, anti-angiogenic agents, and checkpoint inhibitors. New approaches like liquid biopsies, genomics, proteomics, and AI-driven predictive models are all being evaluated as tools for improving cancer detection and treatment selection.

Will relate to bringing the readers up to speed with systematic reviews, recent studies, and research relating to personalized medicine initiatives in the context of gynecologic cancer.

Dr. Hooman Soleymani majd
Dr. Federico Ferrari
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.